No Data
Nissho, Nichias etc (additional) Rating
Upgraded - bullish Code Stock Name Brokerage Firm Previous Change After -------------------------------------------------------------- <4967> Kobayashi Pharmaceutical Mizuho "hold" "buy" <6481> THK City "2" "1" <7186> Concordia JPM "Neutral" "OverW" <7202> Isuzu Mizuho "hold" "buy" Downgraded - bearish Code Stock Name Brokerage Firm Previous Change After -----
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
• List of stocks for sell conversion market Code Stock name Closing price SAR Tokyo main board <1375> Yukiguni Maitake 1028 1052 <1379> Hokuto 1797 1834 <1414> Showa bongrain 5293 5416 <1808> Haseko 1825 1880 <1813> Fudo Tetra 2025 2104 <1821> Mitsumi Construction 387 394 <1893> Go Yo Ken 610 648 <1926> Wright Kogyo 213 62
SoftBank, upward revision on 25/3, operating profit 950 billion yen ← 900 billion yen
SoftBank <9434> announced a revision to its financial estimates for the fiscal year ending in March 2025. The revenue has been upwardly revised from 6.2 trillion yen to 6.35 trillion yen, and the operating profit from 900 billion yen to 950 billion yen. The strong performance of its subsidiary, the leading smart phone payment provider PayPay, as well as the recovery of its mobile business, have contributed to this. [Positive evaluation] <9735> secom co midterm | <4521> Kaken Pharmaceutical midterm <7733> Olympus midterm | <8362> Fukui Bank revision <9005> Tokyu midterm | <4
Nihon Dempa Kogyo's Strong Half-Year Results Exceed Expectations
Nihon Dempa Kogyo: Confirmatory letter.
Nihon Dempa Kogyo: Half Year Report - Term 84 (2024/04/01 - 2025/03/31)
No Data